[1]
«A reduced fixed dose of Tocilizumab 200 mg compared to 400 mg in patients with severe COVID-19 disease», OH&RM, т. 4, вып. 4, сс. 19–26, сен. 2023, doi: 10.38045/ohrm.2023.4.02.